Role of pharmacists in adherence in oncology patients

Adherence is the degree to which the patient’s behaviour and actions correspond to the physician’s established treatment regimen regarding timing, dose and frequency. Patient counselling by both oncologists and pharmacists and optimization of the therapeutic regimen can critically impact decision-ma...

Full description

Saved in:
Bibliographic Details
Main Authors: Zornitsa Mitkova, Stephanie Karanyotova, Jeliazko Arabadjiev, Nikola Radichev, Gabriela Pancheva, Maria Dimitrova
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Biotechnology & Biotechnological Equipment
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/13102818.2024.2359000
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846129301095710720
author Zornitsa Mitkova
Stephanie Karanyotova
Jeliazko Arabadjiev
Nikola Radichev
Gabriela Pancheva
Maria Dimitrova
author_facet Zornitsa Mitkova
Stephanie Karanyotova
Jeliazko Arabadjiev
Nikola Radichev
Gabriela Pancheva
Maria Dimitrova
author_sort Zornitsa Mitkova
collection DOAJ
description Adherence is the degree to which the patient’s behaviour and actions correspond to the physician’s established treatment regimen regarding timing, dose and frequency. Patient counselling by both oncologists and pharmacists and optimization of the therapeutic regimen can critically impact decision-making and adherence to therapy. We performed a two-step study to identify factors influencing adherence to therapy from the perspective of oncology hospital pharmacists in Bulgaria. The results show that the major factors affecting anticancer therapy adherence are the manifestation of adverse drug reactions and distrust in therapy. These could be overcome with improved communication between patients, oncologists and pharmacists on therapy aspects and more active involvement of the hospital pharmacists in therapy monitoring with a main focus on identifying possible drug-related problems based on safety profile, drug-drug interactions and non-adherence.
format Article
id doaj-art-2d5f95c7f5be4229b82a6f1cc209b25f
institution Kabale University
issn 1310-2818
1314-3530
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Biotechnology & Biotechnological Equipment
spelling doaj-art-2d5f95c7f5be4229b82a6f1cc209b25f2024-12-10T05:42:51ZengTaylor & Francis GroupBiotechnology & Biotechnological Equipment1310-28181314-35302024-12-0138110.1080/13102818.2024.2359000Role of pharmacists in adherence in oncology patientsZornitsa Mitkova0Stephanie Karanyotova1Jeliazko Arabadjiev2Nikola Radichev3Gabriela Pancheva4Maria Dimitrova5Department of Organisation and Economy of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaDepartment of Organisation and Economy of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaUniversity Hospital Acibadem City Clinic Tokuda, Sofia, BulgariaDepartment of Organisation and Economy of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaDepartment of Organisation and Economy of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaDepartment of Organisation and Economy of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaAdherence is the degree to which the patient’s behaviour and actions correspond to the physician’s established treatment regimen regarding timing, dose and frequency. Patient counselling by both oncologists and pharmacists and optimization of the therapeutic regimen can critically impact decision-making and adherence to therapy. We performed a two-step study to identify factors influencing adherence to therapy from the perspective of oncology hospital pharmacists in Bulgaria. The results show that the major factors affecting anticancer therapy adherence are the manifestation of adverse drug reactions and distrust in therapy. These could be overcome with improved communication between patients, oncologists and pharmacists on therapy aspects and more active involvement of the hospital pharmacists in therapy monitoring with a main focus on identifying possible drug-related problems based on safety profile, drug-drug interactions and non-adherence.https://www.tandfonline.com/doi/10.1080/13102818.2024.2359000Oncologypatientsadherencepharmacists
spellingShingle Zornitsa Mitkova
Stephanie Karanyotova
Jeliazko Arabadjiev
Nikola Radichev
Gabriela Pancheva
Maria Dimitrova
Role of pharmacists in adherence in oncology patients
Biotechnology & Biotechnological Equipment
Oncology
patients
adherence
pharmacists
title Role of pharmacists in adherence in oncology patients
title_full Role of pharmacists in adherence in oncology patients
title_fullStr Role of pharmacists in adherence in oncology patients
title_full_unstemmed Role of pharmacists in adherence in oncology patients
title_short Role of pharmacists in adherence in oncology patients
title_sort role of pharmacists in adherence in oncology patients
topic Oncology
patients
adherence
pharmacists
url https://www.tandfonline.com/doi/10.1080/13102818.2024.2359000
work_keys_str_mv AT zornitsamitkova roleofpharmacistsinadherenceinoncologypatients
AT stephaniekaranyotova roleofpharmacistsinadherenceinoncologypatients
AT jeliazkoarabadjiev roleofpharmacistsinadherenceinoncologypatients
AT nikolaradichev roleofpharmacistsinadherenceinoncologypatients
AT gabrielapancheva roleofpharmacistsinadherenceinoncologypatients
AT mariadimitrova roleofpharmacistsinadherenceinoncologypatients